ns of devices (e.g., certain studies of lawfully marketed devices)
may be exempt from the IDE regulations [21 CFR 812.2(c)]. Unless exempt from the IDE
regulations, an investigational device must be categorized as either &quot;significant
risk&quot; (SR) or &quot;nonsignificant risk&quot; (NSR). The determination that a device
presents a nonsignificant or significant risk is initially made by the sponsor. The
proposed study is then submitted either to FDA (for SR studies) or to an IRB (for NSR
studies